Clover Health Files 8-K
Ticker: CLOV · Form: 8-K · Filed: Dec 10, 2025 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Dec 10, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-disclosure
Related Tickers: CLOV
TL;DR
CLOV filed a standard 8-K on 12/10/25, no major news.
AI Summary
Clover Health Investments, Corp. filed an 8-K on December 10, 2025, reporting on Regulation FD Disclosure and Financial Statements and Exhibits. The filing indicates no specific new financial figures or material events were detailed in the provided text, but it serves as a standard corporate update.
Why It Matters
This filing is a routine corporate disclosure, indicating that Clover Health is adhering to its reporting obligations with the SEC.
Risk Assessment
Risk Level: low — The filing is a routine 8-K and does not contain information that suggests an immediate change in risk for the company.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- 0001801170-25-000284 (other) — Accession Number
- December 10, 2025 (date) — Date of Report
- Delaware (jurisdiction) — State of Incorporation
- 001-39252 (other) — SEC File Number
- 98-1515192 (other) — IRS Employer Identification No.
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on Regulation FD Disclosure and Financial Statements and Exhibits.
What is the exact name of the registrant filing this report?
The exact name of the registrant is CLOVER HEALTH INVESTMENTS, CORP. /DE.
On what date was this 8-K filed?
The filing was made on December 10, 2025.
In which state is Clover Health Investments, Corp. incorporated?
Clover Health Investments, Corp. is incorporated in Delaware.
What is the SEC file number for Clover Health Investments, Corp.?
The SEC file number for Clover Health Investments, Corp. is 001-39252.
Filing Stats: 619 words · 2 min read · ~2 pages · Grade level 12.2 · Accepted 2025-12-10 16:06:17
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20251210.htm (8-K) — 28KB
- axex991xcphperformanceup.htm (EX-99.1) — 1KB
- axex991xcphperformanceup001.jpg (GRAPHIC) — 138KB
- axex991xcphperformanceup002.jpg (GRAPHIC) — 216KB
- 0001801170-25-000284.txt ( ) — 623KB
- clov-20251210.xsd (EX-101.SCH) — 2KB
- clov-20251210_lab.xml (EX-101.LAB) — 22KB
- clov-20251210_pre.xml (EX-101.PRE) — 13KB
- clov-20251210_htm.xml (XML) — 2KB
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On December 10, 2025, Clover Health Investments, Corp. (the "Company") released information regarding Counterpart Health, Inc.'s ("Counterpart") performance outcomes and third party customer clinician adoption of its Counterpart Assistant technology. Counterpart, a subsidiary of the Company, houses a software as a service and tech-enabled services solution to bring the power of the Company's Clover Assistant technology to external payors and providers serving the Medicare eligible population under the brand name "Counterpart Assistant." The information set forth in this Item 7.01 (including all information in Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), nor shall it be deemed to be incorporated by reference into any filing made under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 99.1 Counterpart Health, Inc. Performance Update 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. Clover Health Investments, Corp. Date: December 10, 2025 By: /s/ Peter Kuipers Name: Peter Kuipers Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)